{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:15:29Z","timestamp":1783329329003,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omton.2026.201205","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:09:53Z","timestamp":1776067793000},"page":"201205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["NeuroD1 gene therapy inhibits glioma growth and extends life span through in vivo reprogramming approach"],"prefix":"10.1016","volume":"34","author":[{"given":"Yuchen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsang-Chih","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuetao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalia S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huitao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1857-3670","authenticated-orcid":false,"given":"Gong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201205_bib1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omton.2026.201205_bib2","first-page":"299","article-title":"Management of glioblastoma: State of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omton.2026.201205_bib3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omton.2026.201205_bib4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201205_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201205_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201205_bib7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/nn.2385","article-title":"Neurod1 is essential for the survival and maturation of adult-born neurons","volume":"12","author":"Gao","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omton.2026.201205_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22802-z","article-title":"Expression level of the reprogramming factor NeuroD1 is critical for neuronal conversion efficiency from different cell types","volume":"12","author":"Matsuda-Ito","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201205_bib9","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.neuron.2016.08.004","article-title":"In Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells","volume":"91","author":"Li","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.omton.2026.201205_bib10","article-title":"Brain-Wide Neuroregenerative Gene Therapy Improves Cognition in a Mouse Model of Alzheimer's Disease","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omton.2026.201205_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymthe.2019.09.003","article-title":"A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron Conversion","volume":"28","author":"Chen","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201205_bib12","article-title":"Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington\u2019s disease","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201205_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102198","article-title":"Neuroregenerative gene therapy to treat temporal lobe epilepsy in a rat model","volume":"208","author":"Zheng","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.omton.2026.201205_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.591883","article-title":"Regeneration of Functional Neurons After Spinal Cord Injury via in situ NeuroD1-Mediated Astrocyte-to-Neuron Conversion","volume":"8","author":"Puls","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omton.2026.201205_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41420-023-01595-8","article-title":"NeuroD4 converts glioblastoma cells into neuron-like cells through the SLC7A11-GSH-GPX4 antioxidant axis","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.omton.2026.201205_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.20892\/j.issn.2095-3941.2020.0499","article-title":"Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion","volume":"18","author":"Wang","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.omton.2026.201205_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cells13110897","article-title":"Reprogramming Glioblastoma Cells into Non-Cancerous Neuronal Cells as a Novel Anti-Cancer Strategy","volume":"13","author":"Jiang","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.omton.2026.201205_bib18","article-title":"Neuronal Transcription Factors Induce Conversion of Human Glioma Cells to Neurons and Inhibit Tumorigenesis","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2026.201205_bib19","doi-asserted-by":"crossref","first-page":"e1463","DOI":"10.1038\/cddis.2014.425","article-title":"Reprogramming the fate of human glioma cells to impede brain tumor development","volume":"5","author":"Su","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2026.201205_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060571","article-title":"Inhibition of Glioma Development by ASCL1-Mediated Direct Neuronal Reprogramming","volume":"8","author":"Cheng","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.omton.2026.201205_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2019.03.049","article-title":"Differentiation of human glioblastoma U87 cells into cholinergic neuron","volume":"704","author":"Liu","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.omton.2026.201205_bib22","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1021\/acschemneuro.8b00365","article-title":"Direct Reprogramming of Glioblastoma Cells into Neurons Using Small Molecules","volume":"9","author":"Lee","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.omton.2026.201205_bib23","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1038\/s41598-019-39852-5","article-title":"Suppression of glioblastoma by a drug cocktail reprogramming tumor cells into neuronal like cells","volume":"9","author":"Gao","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201205_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omton.2026.201205_bib25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41583-024-00829-7","article-title":"Gene therapy for CNS disorders: modalities, delivery and translational challenges","volume":"25","author":"Gao","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.omton.2026.201205_bib26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omton.2026.201205_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2016.01.001","article-title":"Adeno-associated virus (AAV) vectors in cancer gene therapy","volume":"240","author":"Santiago-Ortiz","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omton.2026.201205_bib28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.canlet.2014.10.045","article-title":"Adeno-associated virus-mediated cancer gene therapy: current status","volume":"356","author":"Luo","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2026.201205_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11060-009-9972-7","article-title":"Directed evolution of adeno-associated virus for glioma cell transduction","volume":"96","author":"Maguire","year":"2010","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.omton.2026.201205_bib30","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ymthe.2006.02.004","article-title":"AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma","volume":"13","author":"Harding","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201205_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071889","article-title":"Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives","volume":"12","author":"Hacker","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omton.2026.201205_bib32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/hum.2005.16.381","article-title":"Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts","volume":"16","author":"Huszthy","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omton.2026.201205_bib33","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1038\/s41467-024-49989-1","article-title":"Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade","volume":"15","author":"von Roemeling","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201205_bib34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201205_bib35","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","article-title":"A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo","volume":"76","author":"Hubert","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201205_bib36","article-title":"The generation of glioma organoids and the comparison of two culture methods","volume":"13","author":"Zhang","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.omton.2026.201205_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101420","article-title":"Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing","volume":"33","author":"Xu","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2026.201205_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/science.adn9083","article-title":"In vivo dendritic cell reprogramming for cancer immunotherapy","volume":"386","author":"Ascic","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.omton.2026.201205_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40880-019-0393-5","article-title":"Cancer cell reprogramming: a promising therapy converting malignancy to benignity","volume":"39","author":"Gong","year":"2019","journal-title":"Cancer Commun."},{"key":"10.1016\/j.omton.2026.201205_bib40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41467-020-14855-3","article-title":"Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201205_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","article-title":"Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy","volume":"6","author":"Henke","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omton.2026.201205_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.18","article-title":"Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses","volume":"3","author":"Ungerechts","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2026.201205_bib43","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1038\/s41596-020-0402-9","article-title":"Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing","volume":"15","author":"Jacob","year":"2020","journal-title":"Nat. Protoc."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:21:28Z","timestamp":1783326088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926000810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2950329926000810"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201205","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NeuroD1 gene therapy inhibits glioma growth and extends life span through in vivo reprogramming approach","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201205"}}